4.5 Article

Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid

Journal

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 69, Issue 2, Pages 167-178

Publisher

WILEY
DOI: 10.1111/j.1365-2125.2009.03564.x

Keywords

ciprofloxacin; competitive inhibition; metabolite formation; modelling of pharmacokinetic interaction; probenecid

Ask authors/readers for more resources

AIMS Probenecid influences transport processes of drugs at several sites in the body and decreases elimination of several quinolones. We sought to explore extent, time course, and mechanism of the interaction between ciprofloxacin and probenecid at renal and nonrenal sites. METHODS A randomized, two-way crossover study was conducted in 12 healthy volunteers (in part previously published Clin Pharmacol Ther 1995; 58: 532-41). Subjects received 200 mg ciprofloxacin as 30-min intravenous infusion without and with 3 g probenecid divided into five oral doses. Drug concentrations were analysed by liquid chromatography-tandem mass spectrometry and high-performance liquid chromatography. Ciprofloxacin and its 2-aminoethylamino-metabolite (M1) in plasma and urine with and without probenecid were modelled simultaneously with WinNonlin (R). RESULTS Data are ratio of geometric means (90% confidence intervals). Addition of probenecid reduced the median renal clearance from 23.8 to 8.25 l h(-1) [65% reduction (59, 71), P < 0.01] for ciprofloxacin and from 20.5 to 8.26 l h(-1) (66% reduction (57, 73), P < 0.01] for M1 (estimated by modelling). Probenecid reduced ciprofloxacin nonrenal clearance by 8% (1, 14) (P < 0.08). Pharmacokinetic modelling indicated competitive inhibition of the renal tubular secretion of ciprofloxacin and M1 by probenecid. The affinity for the renal transporter was 4.4 times higher for ciprofloxacin and 3.6 times higher for M1 than for probenecid, based on the molar ratio. Probenecid did not affect volume of distribution of ciprofloxacin or M1, nonrenal clearance or intercompartmental clearance of ciprofloxacin. CONCLUSIONS Probenecid inhibited the renal tubular secretion of ciprofloxacin and M1, probably by a competitive mechanism and due to reaching > 100-fold higher plasma concentrations. Formation of M1, nonrenal clearance and distribution of ciprofloxacin were not affected.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Health Care Sciences & Services

Medication-related Medical Emergency Team activations: a case review study of frequency and preventability

Bianca J. Levkovich, Judit Orosz, Gordon Bingham, D. James Cooper, Michael Dooley, Carl Kirkpatrick, Daryl A. Jones

Summary: Medication-related activations accounted for one-fourth of emergency team activations, often occurring early in a patient's admission. One-third of these medication-related activations were potentially preventable, with the most common causes being omission of beta-blockers and clinically inappropriate use of antihypertensive drugs.

BMJ QUALITY & SAFETY (2023)

Review Pharmacology & Pharmacy

Drug repurposing using real-world data

George S. Q. Tan, Erica K. Sloan, Pete Lambert, Carl M. J. Kirkpatrick, Jenni Ilomaki

Summary: The use of real-world data in drug repurposing is advantageous for supplementing de novo drug discovery and incorporating real-world evidence in regulatory approvals. A scoping review analyzed 250 studies, including hypothesis generation, hypothesis validation, and safety assessment. Challenges include isolated data sources, false-positive signals, bias and confounding in hypothesis validation, and the lack of regulatory guidance.

DRUG DISCOVERY TODAY (2023)

Article Public, Environmental & Occupational Health

Enhanced primary care after hospitalization: General practitioner, pharmacist and patient feedback from the REMAIN HOME trial

Holly Foot, Carl Kirkpatrick, Grant Russell, Nancy Sturman, Amelia Cossart, Christopher Freeman

Summary: The study investigates the attitudes of GPs, patients, and practice pharmacists towards the practice pharmacist model of care in the Australian primary care setting. The results show that the model is well accepted by all stakeholders and has promising evidence for broader implementation in the healthcare setting.

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2023)

Article Microbiology

Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis

Guohua An, C. Buddy Creech, Nan Wu, Roger L. Nation, Kenan Gu, Demet Nalbant, Natalia Jimenez-Truque, William Fissell, Stephanie Rolsma, Pratish C. Patel, Amy Watanabe, Nicholas Fishbane, Carl M. J. Kirkpatrick, Cornelia B. Landersdorfer, Patricia Winokur

Summary: The population pharmacokinetic (PK) analysis of meropenem in 114 critically ill patients showed that the drug's clearance is affected by creatinine clearance and continuous renal replacement therapy, while volume of distribution is influenced by total bodyweight. The developed model serves as a valuable addition to the existing meropenem population PK models and is particularly useful for therapeutic drug monitoring programs with Bayesian forecasting. Monte Carlo simulations demonstrated that the dosing regimens of 2 g every 8 h with 3-h prolonged infusion (PI) and 4 g/day by continuous infusion (CI) are superior in terms of target attainment and potential toxicity when renal function information is unavailable.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Pharmacology & Pharmacy

Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult Lifespan

Marion Hemmersbach-Miller, Stephen J. Balevic, Patricia L. Winokur, Cornelia B. Landersdorfer, Kenan Gu, Austin W. Chan, Michael Cohen-Wolkowiez, Thomas Conrad, Guohua An, Carl M. J. Kirkpatrick, Geeta K. Swamy, Emmanuel B. Walter, Kenneth E. Schmader

Summary: This study evaluated the pharmacokinetics of piperacillin/tazobactam and its changes in older adults. The estimated creatinine clearance had the most significant impact on the elimination clearance of piperacillin and tazobactam. Frailty did not have a remaining impact on their pharmacokinetics after accounting for renal function and body size.

CLINICAL PHARMACOKINETICS (2023)

Article Pharmacology & Pharmacy

Delineating gene-environment effects using virtual twins of patients treated with clozapine

Sam Mostafa, Thomas M. M. Polasek, Chad Bousman, Amin Rostami-Hodjegan, Leslie J. J. Sheffield, Ian Everall, Christos Pantelis, Carl M. J. Kirkpatrick

Summary: Studies that focus on individual covariates and ignore their interactions may not be adequate for model-informed precision dosing (MIPD). This study aimed to construct virtual twins (VTs) of real patients receiving clozapine with interacting covariates related to genetics and environment and to determine the impact of these interacting covariates on predicted clozapine plasma concentrations. The results showed that increasing covariate virtualization improved the accuracy and reliability of the prediction models.

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2023)

Article Microbiology

Penicillin-Binding Protein 5/6 Acting as a Decoy Target in Pseudomonas aeruginosa Identified by Whole-Cell Receptor Binding and Quantitative Systems Pharmacology

Silvia Lopez-Argueello, Maria Montaner, Alaa R. M. Sayed, Antonio Oliver, Jurgen B. Bulitta, Bartolome Moya

Summary: Beta-lactam antibiotics have been effective against susceptible Pseudomonas aeruginosa, but their penetration ability and binding to penicillin-binding proteins (PBPs) in intact bacteria have not been well studied. This research investigated the time course of PBP binding and target site penetration of 15 compounds in P. aeruginosa PAO1. The results showed that PBPs 1-4 were considerably bound in lysed bacteria, but the binding was attenuated in intact bacteria for slow penetrating beta-lactams. Imipenem showed the highest killing effect, while other drugs had lower killing rates. The study also found a correlation between PBP5/6 binding and the rate of net influx and PBP access.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Infectious Diseases

Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients

Guohua An, C. Buddy Creech, Nan Wu, Roger L. Nation, Kenan Gu, Demet Nalbant, Natalia Jimenez-Truque, William Fissell, Pratish C. Patel, Nicholas Fishbane, Amy Watanabe, Stephanie Rolsma, Carl M. J. Kirkpatrick, Cornelia B. Landersdorfer, Patricia Winokur

Summary: This study aimed to identify rational empirical dosing strategies for cefepime treatment in critically ill patients. Continuous infusion of cefepime was found to be a promising strategy with higher breakpoint coverage compared to intermittent infusions. The results of this study can serve as useful references for physicians in making dosing decisions.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Letter Neurosciences

Consistent terminology for medication-related problems in pharmacogenomic cases

Thomas M. Polasek, Sam Mostafa, Carl M. J. Kirkpatrick

JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2023)

Article Biochemistry & Molecular Biology

Novel Xanomeline-Containing Bitopic Ligands of Muscarinic Acetylcholine Receptors: Design, Synthesis and FRET Investigation

Carlo Matera, Michael Kauk, Davide Cirillo, Marco Maspero, Claudio Papotto, Daniela Volpato, Ulrike Holzgrabe, Marco De Amici, Carsten Hoffmann, Clelia Dallanoce

Summary: In recent years, fluorescence resonance energy transfer (FRET) receptor sensors have played a significant role in studying GPCR ligand binding and activation. Researchers have synthesized two series of bitopic ligands, known as 12-Cn and 13-Cn, and examined their pharmacological effects on M-1, M-2, M-4, and M-5 FRET-based receptor sensors. The results showed selective activation of M-1 mAChRs with tertiary amine compounds 12-C5, 12-C7, and 12-C9, while methyl tetrahydropyridinium salts 13-C5, 13-C7, and 13-C9 exhibited some selectivity for M-1 and M-4 mAChRs. These findings provide insights into ligand-receptor interactions at a molecular level and offer new tools for studying them.

MOLECULES (2023)

Article Chemistry, Medicinal

Analytical Quality by Design: Achieving Robustness of an LC-CAD Method for the Analysis of Non-Volatile Fatty Acids

Rasmus Walther, Jovana Krmar, Adrian Leistner, Bojana Svrkota, Biljana Otasevic, Andjelija Malenovic, Ulrike Holzgrabe, Ana Protic

Summary: A robust liquid chromatography method with charged aerosol detection was proposed as an alternative to the time-consuming and error-prone pharmacopoeial gas chromatography method for the analysis of fatty acids (FAs). The method utilized a gradient method with a Hypersil Gold C-18 column and acetonitrile as organic modifier to analyze polysorbate 80 (PS80) and magnesium stearate. Risk-based Analytical Quality by Design approach was applied to define the Method Operable Design Region (MODR), with critical method parameters (CMPs) including formic acid concentration, initial and final percentages of acetonitrile, gradient elution time, column temperature, and mobile phase flow rate.

PHARMACEUTICALS (2023)

Article Health Policy & Services

An evaluation of the Australian Community Pharmacy Agreement from a public policy perspective: industry policy cloaked as health policy?

John K. Jackson, Shane L. Scahill, Michael Mintrom, Carl M. Kirkpatrick

Summary: Since 1990, the Community Pharmacy Agreements (Agreements) between the Australian Federal government and the Pharmacy Guild of Australia (PGA) have had a significant impact on Australian community pharmacy. The Agreements primarily focus on dispensing remuneration and restrictions on the establishment of new pharmacies. Criticisms include the self-interest of pharmacy owners, lack of transparency, and impact on competition.

JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE (2023)

Article Microbiology

Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance

Jessica R. R. Tait, Marina Harper, Sara Cortes-Lara, Kate E. E. Rogers, Carla Lopez-Causape, Thomas R. R. Smallman, Yinzhi Lang, Wee Leng Lee, Jieqiang Zhou, Jurgen B. Bulitta, Roger L. L. Nation, John D. D. Boyce, Antonio Oliver, Cornelia B. B. Landersdorfer

Summary: The study evaluated the efficacy of ceftolozane-tazobactam against multidrug-resistant hypermutable P. aeruginosa isolates in cystic fibrosis (CF) using the hollow-fiber infection model. Results showed that isolates CW41 and CW44 harbored preexisting resistant subpopulations while CW35 did not. This emphasizes the importance of using ceftolozane-tazobactam in combination with another antibiotic in CF patients.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Pharmacology & Pharmacy

Exploring the role of ex vivo metabolism on blood and plasma measurements of oxytocin among women in the third stage of labour: A post hoc study

Victoria L. Oliver, Sarah Siederer, Anthony Cahn, Katarzyna Gajewska-Knapik, Rachel A. Gibson, Cleo Goodall, Carl Kirkpatrick, Jack Murray, Tri-Hung Nguyen, Ian Schneider, Pete Lambert, Michelle P. Mcintosh, Simon Parry

Summary: This study examines the role of ex vivo oxytocin metabolism and stability in late-stage pregnancy blood. The findings suggest that collecting blood into tubes containing EDTA effectively stabilizes oxytocin and inhibits oxytocinase activity. The measured concentrations of oxytocin vary between different analytical methods.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Surgery

Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination

Steven Ivulich, Eldho Paul, Carl Kirkpatrick, Michael Dooley, Greg Snell

Summary: Everolimus (EVE) is an alternative immunosuppressive agent for lung transplant recipients (LTR) who cannot tolerate conventional immunosuppression. It can be used as part of a calcineurin inhibitor (CNI) minimization or elimination strategy. This study compared the safety and efficacy outcomes of EVE in LTR receiving either a CNI minimization or elimination regimen. The results showed that LTR receiving EVE as part of the CNI elimination strategy had poorer survival outcomes, while the utilization of EVE for renal preservation was associated with improved survival. The study highlighted the importance of retaining a low dose CNI in immunosuppressive regimens for superior survival outcomes.

TRANSPLANT INTERNATIONAL (2023)

No Data Available